Warner Chilcott PLC (WCRX): Today's Featured Health Care Laggard

Warner Chilcott ( WCRX) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 0.6%. By the end of trading, Warner Chilcott fell $0.31 (-1.6%) to $19.53 on light volume. Throughout the day, 2,496,994 shares of Warner Chilcott exchanged hands as compared to its average daily volume of 7,376,900 shares. The stock ranged in price between $19.49-$19.95 after having opened the day at $19.86 as compared to the previous trading day's close of $19.84. Other companies within the Health Care sector that declined today were: Pingtan Marine Enterprise ( PME), down 70.0%, Mast Therapeutics ( MSTX), down 34.9%, GTx ( GTXI), down 25.2% and NeoGenomics ( NEO), down 18.1%.

Warner Chilcott Public Limited Company, a specialty pharmaceutical company, engages in the development, manufacture, promotion, and franchise of branded pharmaceutical products focusing on the women's healthcare, gastroenterology, urology, and dermatology markets. Warner Chilcott has a market cap of $5.0 billion and is part of the drugs industry. Shares are down 2.1% year to date as of the close of trading on Tuesday. Currently there are 5 analysts that rate Warner Chilcott a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Warner Chilcott as a hold. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year and expanding profit margins. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall.

On the positive front, USMD Holdings ( USMD), up 26.1%, Inovio Pharmaceuticals ( INO), up 24.6%, American Shared Hospital Services ( AMS), up 20.1% and China Pharma ( CPHI), up 14.9% , were all gainers within the health care sector with Allergan ( AGN) being today's featured health care sector leader.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Canopy Growth Lets Down Eager Pot Investors; PayPal Keeps Dominating -- ICYMI

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Dow, S&P 500 and Nasdaq Tumble After Trump Calls Off North Korea Summit

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

3 Must Reads on the Market From TheStreet's Top Columnists

3 Must Reads on the Market From TheStreet's Top Columnists

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers

Automakers Slump as Trump Tariffs Threaten Both Manufacturers and Consumers